New Delhi, March 21 Pharmaceutical companies Torrent Pharmaceuticals, Alkem Laboratories, and USV Ltd. launched Semaglutide-based generic diabetes treatment medication in the country on Saturday.Torrent Pharma launched its Semaglutide brands, Sembolic and Semalix, in both oral and injectable...
New Delhi, March 20 Eris Lifesciences launched a generic version of Semaglutide under the brand name 'Sundae' in the country on Friday, capitalizing on the expiration of patents for molecules similar to Ozempic and Wegovy in India.The company stated that it is introducing the diabetes and...
New Delhi, March 8 A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).Cipla USA, Inc, based in Warren (New Jersey), is recalling Nilotinib Capsules in...
anti-cancer medication
cancer treatment
cipla
cipla usa, inc
class iii recall
drug supply
genericmedication
manufacturing defect
nilotinib
pharmaceutical industry
pharmaceutical manufacturing
pharmaceutical recall
us food and drug administration (usfda)
us prescription drugs
warren (new jersey)
New Delhi, February 26 Alembic Pharmaceuticals announced on Thursday that it has received approval from the US health regulator to market a generic medication for seizures.The drug company has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug...
New Delhi, February 25 Drug firm Lupin announced on Wednesday that it has received approval from the US health regulator to market a generic medication to treat seizures.The Mumbai-based firm has received approval from the USFDA for its abbreviated new drug application (ANDA) for Brivaracetam...
anda
brivaracetam
briviact
bse
drug approval
genericmedication
india
lupin
oral solution
pharmaceutical industry
pharmaceutical sales
seizures
us market
usfda
New Delhi, February 24 Alembic Pharmaceuticals announced on Tuesday that it has received approval from the US health regulator to market a generic antifungal medication.The company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution...
New Delhi, February 11 OneSource Speciality Pharma announced on Wednesday that, along with Hikma, it has received approval from the Saudi Food and Drug Authority for a generic version of the diabetes and weight reduction medication Ozempic.The company has partnered with Hikma Pharmaceuticals...
diabetes treatment
genericmedication
hikma pharmaceuticals
mena region
onesource speciality pharma
ozempic
saudi food and drug authority
semaglutide
weight reduction medication